Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAR | AMGN | VRTX | BMY | GILD |
| Company | Pharming Group N.V. ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 7.51 | 277.67 | 462.80 | 56.50 | 87.63 |
| High | 7.55 | 280.48 | 463.90 | 57.89 | 88.60 |
| Low | 7.47 | 275.56 | 458.16 | 56.10 | 86.08 |
| Last | 7.55 | 279.47 | 462.56 | 57.94 | 88.39 |
| Change | -0.20 | +0.71 | -4.45 | +1.14 | -0.07 |
| % Change | -2.63% | +0.25% | -0.95% | +2.01% | -0.08% |
| Volume | 1,716 | 775,087 | 280,463 | 3,014,708 | 2,106,643 |
| 20-Day Average Volume | 6,696 | 2,524,667 | 1,174,639 | 11,592,602 | 7,355,916 |
| Previous Close | 7.75 | 278.76 | 467.01 | 56.80 | 88.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.30 | 310.03 | 481.97 | 55.39 | 90.81 |
| 20-Day Raw Stochastic | 3.62% | 7.25% | 6.95% | 63.54% | 19.28% |
| 20-Day Relative Strength | 42.00% | 27.40% | 43.79% | 59.97% | 50.89% |
| Weighted Alpha | -36.19 | -3.16 | +22.46 | +24.48 | +23.78 |
| Today's Opinion | 56% Sell | 40% Sell | 8% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 56% Sell | 40% Sell | 32% Buy | 100% Buy | 80% Buy |
| Last Month's Opinion | 8% Buy | 8% Buy | 56% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.68% since 11/12/24 | -6.51% since 11/12/24 | -5.64% since 11/12/24 | -2.24% since 11/12/24 | -6.12% since 11/12/24 |
| Low | 7.47 on 11/19/24 | 275.56 on 11/19/24 | 458.05 on 11/18/24 | 55.82 on 11/15/24 | 86.11 on 11/19/24 |
| High | 8.28 on 11/14/24 | 307.43 on 11/13/24 | 498.25 on 11/13/24 | 59.73 on 11/14/24 | 94.21 on 11/13/24 |
| 1-Month | |||||
| %Chg | -17.63% since 10/18/24 | -13.14% since 10/18/24 | -4.28% since 10/18/24 | +8.42% since 10/18/24 | +2.14% since 10/18/24 |
| Low | 7.47 on 11/19/24 | 275.56 on 11/19/24 | 458.05 on 11/18/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 9.56 on 10/23/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -5.44% since 08/19/24 | -14.82% since 08/19/24 | -5.27% since 08/19/24 | +17.04% since 08/19/24 | +18.98% since 08/19/24 |
| Low | 6.73 on 09/09/24 | 275.56 on 11/19/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 74.34 on 08/20/24 |
| High | 9.56 on 10/23/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -18.86% since 05/17/24 | -10.59% since 05/17/24 | +3.85% since 05/17/24 | +31.05% since 05/17/24 | +30.80% since 05/17/24 |
| Low | 6.65 on 07/29/24 | 275.56 on 11/19/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 10.00 on 06/06/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 525,721 | 149,842,704 | 120,268,624 | 115,200,448 | 110,244,688 |
| Shares Outstanding, K | 67,835 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 245,320,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -10,550,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 74,850,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -1,030,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.13 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 10/24/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/24/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.76 | 0.00 | 48.05 | 19.95 |